Hepatocellular adenoma epidemiology and demographics: Difference between revisions
(→Age) |
|||
| Line 14: | Line 14: | ||
==Age== | ==Age== | ||
* The hepatocellular adenoma is more common in woman of childbearing age who take oral contraceptives. | |||
==Gender== | ==Gender== | ||
Women are more commonly affected with hepatocellular adenoma than males. | Women are more commonly affected with hepatocellular adenoma than males. | ||
Revision as of 15:00, 28 December 2018
|
Hepatocellular adenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hepatocellular adenoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Hepatocellular adenoma epidemiology and demographics |
|
Hepatocellular adenoma epidemiology and demographics in the news |
|
Blogs on Hepatocellular adenoma epidemiology and demographics |
|
Risk calculators and risk factors for Hepatocellular adenoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
The incidence of hepatocellular adenoma is approximately 3 per 100,000 individuals worldwide.[1] It is a rare benign tumor that is mainly found in women of child-bearing age.[2]
Epidemiology and demographics
- The hepatocellular adenoma is more common in women in western countries, where they are exposed to higher doses of oral contraceptives.
- Hepatocellular adenoma is rare in regions where oral contraception is not widely used, such as asia.
- The prevalence of hepatocellular adenoma was increased in 1970s following the introduction of oral contraception in western countries.
Incidence
- The estimated incidence of hepatocellular adenoma is 3 per 1,000,000/year.[1]
- The annual incidence is substantially higher with long term oral contraceptive use, estimated at 3 to 4 per 100,000, but may be less with newer oral contraceptives.
Age
- The hepatocellular adenoma is more common in woman of childbearing age who take oral contraceptives.
Gender
Women are more commonly affected with hepatocellular adenoma than males.
References
- ↑ 1.0 1.1 Barthelmes L, Tait IS (2005). "Liver cell adenoma and liver cell adenomatosis". HPB (Oxford). 7 (3): 186–96. doi:10.1080/13651820510028954. PMC 2023950. PMID 18333188.
- ↑ Introduction. Hindawi(2015). http://www.hindawi.com/journals/ijh/2013/374170. Accessed on November 2, 2015